electroCore, Inc. Revenue
electroCore, Inc. (ECOR) reported Revenue of $9.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-06
- electroCore, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $9.45M, a 28.03% increase year-over-year.
- electroCore, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $9.58M, a 42.64% increase year-over-year.
- electroCore, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $9.24M, a 31.18% increase year-over-year.
- electroCore, Inc. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $8.69M, a 32.58% increase year-over-year.
- electroCore, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $32.03M, a 27.20% increase from fiscal 2024.
- electroCore, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $25.18M, a 57.09% increase from fiscal 2023.
- electroCore, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $16.03M, a 86.57% increase from fiscal 2022.
- electroCore, Inc. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $8.59M, a 57.62% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.45M 10-Q · filed 2026-08-06 | $19.03M 10-Q · filed 2026-08-06 | $28.28M derived: sum of 3 quarters · filed 2026-08-06 | $36.97M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $9.58M 10-Q · filed 2026-05-06 | $18.83M derived: sum of 2 quarters · filed 2026-05-06 | $27.52M derived: sum of 3 quarters · filed 2026-05-06 | $34.90M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $9.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $17.93M derived: sum of 2 quarters · filed 2026-03-19 | $25.31M derived: sum of 3 quarters · filed 2026-08-06 | $32.03M 10-K · filed 2026-03-19 | ||||
| 2025-09-30 | $8.69M 10-Q · filed 2025-11-05 | $16.07M derived: sum of 2 quarters · filed 2026-08-06 | $22.79M 10-Q · filed 2025-11-05 | $29.84M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $7.38M 10-Q · filed 2026-08-06 | $14.10M 10-Q · filed 2026-08-06 | $21.15M derived: sum of 3 quarters · filed 2026-08-06 | $27.70M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $6.72M 10-Q · filed 2026-05-06 | $13.77M derived: sum of 2 quarters · filed 2026-05-06 | $20.32M derived: sum of 3 quarters · filed 2026-05-06 | $26.46M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $7.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $13.60M derived: sum of 2 quarters · filed 2026-03-19 | $19.74M derived: sum of 3 quarters · filed 2026-03-19 | $25.18M 10-K · filed 2026-03-19 | ||||
| 2024-09-30 | $6.55M 10-Q · filed 2025-11-05 | $12.69M derived: sum of 2 quarters · filed 2025-11-05 | $18.14M 10-Q · filed 2025-11-05 | $23.33M derived: sum of 4 quarters · filed 2025-11-05 | ||||
| 2024-06-30 | $6.14M 10-Q · filed 2025-08-06 | $11.58M 10-Q · filed 2025-08-06 | $16.77M derived: sum of 3 quarters · filed 2025-08-06 | $21.28M derived: sum of 4 quarters · filed 2025-08-06 | ||||
| 2024-03-31 | $5.44M 10-Q · filed 2025-05-07 | $10.63M derived: sum of 2 quarters · filed 2025-05-07 | $15.14M derived: sum of 3 quarters · filed 2025-05-07 | $18.69M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | $5.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | $9.70M derived: sum of 2 quarters · filed 2025-03-12 | $13.25M derived: sum of 3 quarters · filed 2025-03-12 | $16.03M 10-K · filed 2024-03-13 | ||||
| 2023-09-30 | $4.51M 10-Q · filed 2024-11-13 | $8.06M derived: sum of 2 quarters · filed 2024-11-13 | $10.84M 10-Q · filed 2024-11-13 | $13.40M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $3.55M 10-Q · filed 2024-08-07 | $6.33M 10-Q · filed 2024-08-07 | $8.89M derived: sum of 3 quarters · filed 2024-08-07 | $10.87M derived: sum of 4 quarters · filed 2024-08-07 | ||||
| 2023-03-31 | $2.78M 10-Q · filed 2024-05-08 | $5.34M derived: sum of 2 quarters · filed 2024-05-08 | $7.32M derived: sum of 3 quarters · filed 2024-05-08 | $9.47M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $2.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $4.54M derived: sum of 2 quarters · filed 2024-03-13 | $6.69M derived: sum of 3 quarters · filed 2024-03-13 | $8.59M 10-K · filed 2024-03-13 | ||||
| 2022-09-30 | $1.98M 10-Q · filed 2023-11-08 | $4.13M derived: sum of 2 quarters · filed 2023-11-08 | $6.03M 10-Q · filed 2023-11-08 | $7.52M derived: sum of 4 quarters · filed 2023-11-08 | ||||
| 2022-06-30 | $2.16M 10-Q · filed 2023-08-09 | $4.06M 10-Q · filed 2023-08-09 | $5.55M derived: sum of 3 quarters · filed 2023-08-09 | $7.03M derived: sum of 4 quarters · filed 2023-08-09 | ||||
| 2022-03-31 | $1.90M 10-Q · filed 2023-05-03 | $3.39M derived: sum of 2 quarters · filed 2023-05-03 | $4.88M derived: sum of 3 quarters · filed 2023-05-03 | $6.15M derived: sum of 4 quarters · filed 2023-05-03 | ||||
| 2021-12-31 | $1.49M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $2.98M derived: sum of 2 quarters · filed 2023-03-08 | $4.25M derived: sum of 3 quarters · filed 2023-03-08 | $5.45M 10-K · filed 2023-03-08 | $5.45M 10-K · filed 2022-03-10 | |||
| 2021-09-30 | $1.49M 10-Q · filed 2022-11-03 | $1.49M 10-Q · filed 2021-11-04 | $2.76M derived: sum of 2 quarters · filed 2022-11-03 | $3.96M 10-Q · filed 2022-11-03 | $3.96M 10-Q · filed 2021-11-04 | $4.89M derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2021-06-30 | $1.27M 10-Q · filed 2022-08-04 | $1.27M 10-Q · filed 2021-08-05 | $2.47M 10-Q · filed 2022-08-04 | $2.47M 10-Q · filed 2021-08-05 | $3.40M derived: sum of 3 quarters · filed 2022-08-04 | $4.48M derived: sum of 4 quarters · filed 2022-08-04 | ||
| 2021-03-31 | $1.20M 10-Q · filed 2022-05-05 | $1.20M 10-Q · filed 2021-05-06 | $2.13M derived: sum of 2 quarters · filed 2022-05-05 | $3.21M derived: sum of 3 quarters · filed 2022-05-05 | $3.97M derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | $928.26K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $2.01M derived: sum of 2 quarters · filed 2022-03-10 | $2.76M derived: sum of 3 quarters · filed 2022-03-10 | $3.50M 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | $1.08M 10-Q · filed 2021-11-04 | $1.83M derived: sum of 2 quarters · filed 2021-11-04 | $2.57M 10-Q · filed 2021-11-04 | $3.24M derived: sum of 4 quarters · filed 2021-11-04 | ||||
| 2020-06-30 | $752.96K 10-Q · filed 2021-08-05 | $1.49M 10-Q · filed 2021-08-05 | $2.16M derived: sum of 3 quarters · filed 2021-08-05 | $2.84M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $733.77K 10-Q · filed 2021-05-06 | $1.41M derived: sum of 2 quarters · filed 2021-05-06 | $2.09M derived: sum of 3 quarters · filed 2021-05-06 | $2.71M derived: sum of 4 quarters · filed 2021-05-06 | ||||
| 2019-12-31 | $674.94K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $1.36M derived: sum of 2 quarters · filed 2021-03-11 | $1.98M derived: sum of 3 quarters · filed 2021-03-11 | $2.39M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $682.99K 10-Q · filed 2020-11-12 | $1.31M derived: sum of 2 quarters · filed 2020-11-12 | $1.72M 10-Q · filed 2020-11-12 | $2.08M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $622.74K 10-Q · filed 2020-08-13 | $1.03M 10-Q · filed 2020-08-13 | $1.40M derived: sum of 3 quarters · filed 2020-08-13 | $1.55M derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $409.60K 10-Q · filed 2020-05-15 | $777.60K derived: sum of 2 quarters · filed 2020-05-15 | $928.57K derived: sum of 3 quarters · filed 2020-05-15 | $1.32M derived: sum of 4 quarters · filed 2020-05-15 | ||||
| 2018-12-31 | $368.00K 10-K · filed 2019-03-28 | $518.97K derived: sum of 2 quarters · filed 2019-11-14 | $912.20K derived: sum of 3 quarters · filed 2019-11-14 | $992.95K 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $150.97K 10-Q · filed 2019-11-14 | $544.20K derived: sum of 2 quarters · filed 2019-11-14 | $625.38K 10-Q · filed 2019-11-14 | $859.38K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $393.23K 10-Q · filed 2019-08-14 | $474.41K 10-Q · filed 2019-08-14 | $708.41K derived: sum of 3 quarters · filed 2019-08-14 | $991.41K derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | $81.19K 10-Q · filed 2019-05-15 | $81.00K 10-K · filed 2019-03-28 | $315.19K derived: sum of 2 quarters · filed 2019-05-15 | $598.19K derived: sum of 3 quarters · filed 2019-05-15 | $775.19K derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | $234.00K 10-K · filed 2019-03-28 | $517.00K derived: sum of 2 quarters · filed 2019-03-28 | $694.00K derived: sum of 3 quarters · filed 2019-03-28 | $811.46K 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | $283.00K 10-K · filed 2019-03-28 | $283.24K 10-Q · filed 2018-11-14 | $460.00K derived: sum of 2 quarters · filed 2019-03-28 | $576.73K 10-Q · filed 2018-11-14 | ||||
| 2017-06-30 | $177.00K 10-K · filed 2019-03-28 | $176.56K 10-Q · filed 2018-08-14 | $293.49K 10-Q · filed 2018-08-14 | |||||
| 2017-03-31 | $117.00K 10-K · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |